DOSAGE AND ADMINISTRATION OF MONOSPECIFIC AND BISPECIFIC ANTI-IGF-1R AND ANTI-ERBB3 ANTIBODIES

摘要

Provided are methods for the administration of therapeutic bispecific anti-IGF-lR and anti-ErbB3 antibodies, either alone or in combination with other anti-cancer therapeutics.